UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 321

Sortiert nach

Recommendations for the use of antiemetics : Evidence-based, clinical practice guidelines

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2971-2994

1999

Volltextzugriff (PDF)

Clinical Guidelines for the Treatment of Cancer-Related Anemia

Pharmacotherapy, 1998-01, Vol.18 (1), p.156-169

Koeller, Jim M.

1998

Volltextzugriff (PDF)

Recombinant Interleukin-2

Pharmacotherapy, 1994-11, Vol.14 (6), p.635-656

1994

Volltextzugriff (PDF)

Procedure costs and outcomes associated with pharmacologic management of peripheral arterial disease in the department of defense

Clinical therapeutics, 1999-08, Vol.21 (8), p.1358-1369

1999

Volltextzugriff (PDF)

Fax technology for collecting outcomes data in a computer database

American journal of health-system pharmacy, 1999-12, Vol.56 (24), p.2540-2542

1999

Volltextzugriff (PDF)

Biologic response modifiers: the interferon alfa experience

American journal of hospital pharmacy, 1989-11, Vol.46 (11 Suppl 2), p.S11

Koeller, J M

1989

Volltextzugriff (PDF)

Phase I clinical trial and pharmacokinetics of carboplatin (nsc 241240) by single monthly 30‐minute infusion

Cancer, 1986-01, Vol.57 (2), p.222-225

1986

Volltextzugriff (PDF)

Idarubicin: a second-generation anthracycline

DICP (Cincinnati, Ohio), 1991-05, Vol.25 (5), p.505

1991

Volltextzugriff (PDF)

Understanding cancer pain

American journal of hospital pharmacy, 1990-08, Vol.47 (8 Suppl), p.S3

Koeller, J M

1990

Volltextzugriff (PDF)

Total direct and segmented medical cost-of-care for stage IV (adv) non-small cell lung cancer (NSCLC) in a private insurance population

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e16540-e16540

2011

Volltextzugriff (PDF)

Nutritional Parameters Observed During 28-Day Infusion of Recombinant Human Tumor Necrosis Factor-α

JPEN. Journal of parenteral and enteral nutrition, 1993-11, Vol.17 (6), p.541-545

1993

Volltextzugriff (PDF)

A phase I clinical and pharmacokinetic trial of hepsulfam

Cancer research (Chicago, Ill.), 1991-12, Vol.51 (23), p.6268-6272

1991

Volltextzugriff (PDF)

Economic analysis of carboplatin versus cisplatin in lung and ovarian cancer

PharmacoEconomics, 1999-07, Vol.16 (1), p.43-57

1999

Volltextzugriff (PDF)

Defining significant adverse events (AEs) in advanced colorectal cancer (Adv CRC) patients in the community oncology practice setting

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.6017-6017

2006

Volltextzugriff (PDF)

Antiemetic guidelines: creating a more practical treatment approach

Supportive care in cancer, 2002-10, Vol.10 (7), p.519-522

2002

Volltextzugriff (PDF)

Rational use of antibiotics in the critically ill patient

DICP (Cincinnati, Ohio), 1990-11, Vol.24 (11 Suppl), p.S17

Koeller, J M

1990

Volltextzugriff (PDF)

Impact of newer treatment strategies on end of life chemotherapy for advanced NSCLC

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8076-8076

2004

Volltextzugriff (PDF)

Impact of newer treatment strategies on end of life chemotherapy for advanced NSCLC

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8076-8076

2004

Volltextzugriff (PDF)

Phase I clinical trial of carbetimer

Cancer research (Chicago, Ill.), 1988-09, Vol.48 (18), p.5353-5357

1988

Volltextzugriff (PDF)

Correlations between leukocyte count and absolute granulocyte count in patients receiving cancer chemotherapy

Cancer, 1985-09, Vol.56 (6), p.1350-1355

1985

Volltextzugriff (PDF)

Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage

Cancer research (Chicago, Ill.), 1988-10, Vol.48 (19), p.5585-5590

1988

Volltextzugriff (PDF)

Acute emesis: moderately emetogenic chemotherapy

Supportive care in cancer, 2005-02, Vol.13 (2), p.97-103

2005

Volltextzugriff (PDF)

Impact of Atypical Coverage for Patients with Community-Acquired Pneumonia Managed on the Medical Ward: Results from the United States Community-Acquired Pneumonia Project

Pharmacotherapy, 2003-09, Vol.23 (9), p.1167-1174

2003

Volltextzugriff (PDF)

Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule

Cancer research (Chicago, Ill.), 1990-12, Vol.50 (23), p.7496-7500

1990

Volltextzugriff (PDF)

Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses

Cancer treatment reports, 1982-05, Vol.66 (5), p.1215

1982

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(252)
Mit Volltextzugriff
(260)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Humans
(136)
Life Sciences & Biomedicine
(128)
Biological And Medical Sciences
(66)
Male
(49)
Female
(47)
Medical Sciences
(47)
Animals
(38)
Adult
(35)
Middle Aged
(32)
Pharmacology. Drug Treatments
(29)
Oncology
(28)
Pharmacology & Pharmacy
(24)
Fundamental And Applied Biological Sciences. Psychology
(22)
Neoplasms - Drug Therapy
(19)
Aged
(18)
Mice
(17)
Antineoplastic Agents
(16)
Drug Evaluation
(16)
Antineoplastic Agents - Adverse Effects
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recommendations for the use of antiemetics : Evidence-based, clinical practice guidelines

Clinical Guidelines for the Treatment of Cancer-Related Anemia

Recombinant Interleukin-2

Procedure costs and outcomes associated with pharmacologic management of peripheral arterial disease in the department of defense

Fax technology for collecting outcomes data in a computer database

Biologic response modifiers: the interferon alfa experience

Phase I clinical trial and pharmacokinetics of carboplatin (nsc 241240) by single monthly 30‐minute infusion

Idarubicin: a second-generation anthracycline

Understanding cancer pain

Total direct and segmented medical cost-of-care for stage IV (adv) non-small cell lung cancer (NSCLC) in a private insurance population

Nutritional Parameters Observed During 28-Day Infusion of Recombinant Human Tumor Necrosis Factor-α

A phase I clinical and pharmacokinetic trial of hepsulfam

Economic analysis of carboplatin versus cisplatin in lung and ovarian cancer

Defining significant adverse events (AEs) in advanced colorectal cancer (Adv CRC) patients in the community oncology practice setting

Antiemetic guidelines: creating a more practical treatment approach

Rational use of antibiotics in the critically ill patient

Impact of newer treatment strategies on end of life chemotherapy for advanced NSCLC

Impact of newer treatment strategies on end of life chemotherapy for advanced NSCLC

Phase I clinical trial of carbetimer

Correlations between leukocyte count and absolute granulocyte count in patients receiving cancer chemotherapy

Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage

Acute emesis: moderately emetogenic chemotherapy

Impact of Atypical Coverage for Patients with Community-Acquired Pneumonia Managed on the Medical Ward: Results from the United States Community-Acquired Pneumonia Project

Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule

Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses

Suchergebnisse filtern